Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.19.2
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2019
Income Taxes  
Schedule of Comprehensive Income (Loss)

The components of net loss consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

    

For the Years Ended

 

 

June 30, 

 

 

2019

 

2018

United States

 

$

(17,576)

 

$

(16,076)

Brazil

 

 

(21)

 

 

(32)

Total

 

$

(17,597)

 

$

(16,108)

 

Schedule of Components of Income Tax Expense (Benefit)

The components of the provision (benefit) for income taxes consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

For the Years Ended

 

 

June 30, 

 

 

2019

 

2018

Current – Federal, state and foreign

 

$

 —

 

$

 —

Deferred – Federal

    

 

(3,690)

    

 

3,318

Deferred – State

 

 

(990)

 

 

943

Deferred – Foreign

 

 

 —

 

 

(8)

Total

 

 

(4,680)

 

 

4,253

Change in valuation allowance

 

 

4,680

 

 

(4,253)

Income tax expense

 

$

 —

 

$

 —

 

Schedule of Deferred Tax Assets and Liabilities

The components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

 

 

 

 

 

 

 

 

 

    

As of June 30, 

 

    

2019

 

2018

Deferred tax assets (liabilities):

 

 

 

 

 

 

Net operating loss

 

$

21,427

 

$

15,652

Share-based compensation

 

 

2,236

 

 

2,211

Research and development tax credits

 

 

1,534

 

 

1,404

Suspended losses in iBio CDMO

 

 

 —

 

 

1,223

Basis in iBio CDMO

 

 

687

 

 

678

Intangible assets

 

 

(233)

 

 

(202)

Vacation accrual and other

 

 

19

 

 

24

Valuation allowance

 

 

(25,670)

 

 

(20,990)

Total

 

$

 —

 

$

 —

 

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the statutory tax rate to the effective tax rate is as follows:

 

 

 

 

 

 

 

 

    

Years Ended

 

 

 

June 30, 

 

 

    

2019

    

2018

 

Statutory federal income tax rate

 

21

%  

21

%

State (net of federal benefit)

 

 6

%  

 6

%

Research and development tax credit

 

 1

%  

 1

%

Permanent differences

 

 —

%  

 —

%

Reclassification of incentive stock options to non-qualifying

 

 —

%  

 —

%

Change in federal rate

 

 —

%  

(56)

%

Change in valuation allowance

 

(28)

%  

28

%

Effective income tax rate

 

 —

%  

 —

%